Net Cash Provided by (Used in) Financing Activities of NANOVIRICIDES, INC. from 30 Jun 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NANOVIRICIDES, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Jun 2010 to 30 Sep 2025.
  • NANOVIRICIDES, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Sep 2025 was $1,245,319, a 27% decline year-over-year.
  • NANOVIRICIDES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $5,296,429, a 70% increase from 2024.
  • NANOVIRICIDES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $3,120,037.
  • NANOVIRICIDES, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $94,788, a 60% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NANOVIRICIDES, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $1,245,319 -$464,819 -27% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q1
Q3 2024 $1,710,138 +$1,710,138 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q1
Q3 2023 $0 +$70,951 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2025 Q1
Q3 2022 $70,951 +$388 +0.54% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2022 2023 Q1
Q3 2021 $71,339 -$10,425,497 -101% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2023 Q1
Q3 2020 $10,354,158 +$10,596,263 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q1
Q3 2019 $242,105 01 Jul 2019 30 Sep 2019 10-Q 16 Nov 2020 2020 Q1
Q3 2013 $9,876,074 +$9,876,074 01 Jul 2013 30 Sep 2013 10-Q/A 18 Nov 2013 2014 Q1
Q3 2012 $0 -$2,360,654 -100% 01 Jul 2012 30 Sep 2012 10-Q/A 18 Nov 2013 2014 Q1
Q3 2011 $2,360,654 +$65,654 +2.9% 01 Jul 2011 30 Sep 2011 10-Q 19 Nov 2012 2013 Q1
Q3 2010 $2,295,000 01 Jul 2010 30 Sep 2010 10-Q/A 12 Dec 2011 2012 Q1

NANOVIRICIDES, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $5,296,429 +$2,176,392 +70% 01 Jul 2024 30 Jun 2025 10-K 29 Sep 2025 2025 FY
2024 $3,120,037 +$3,214,825 01 Jul 2023 30 Jun 2024 10-K 29 Sep 2025 2025 FY
2023 $94,788 +$139,928 +60% 01 Jul 2022 30 Jun 2023 10-K 27 Sep 2024 2024 FY
2022 $234,716 -$15,495,400 -102% 01 Jul 2021 30 Jun 2022 10-K 13 Oct 2023 2023 FY
2021 $15,260,684 -$2,566,944 -14% 01 Jul 2020 30 Jun 2021 10-K 13 Oct 2022 2022 FY
2020 $17,827,628 +$15,477,628 +659% 01 Jul 2019 30 Jun 2020 10-K 12 Oct 2021 2021 FY
2019 $2,350,000 +$2,350,000 01 Jul 2018 30 Jun 2019 10-K 12 Oct 2021 2021 FY
2018 $0 +$1,000,000 01 Jul 2017 30 Jun 2018 10-K 13 Oct 2020 2020 FY
2017 $1,000,000 01 Jul 2016 30 Jun 2017 10-K 23 Aug 2019 2019 FY
2013 $6,510,963 -$2,816,537 -30% 30 Jun 2012 30 Jun 2013 10-K/A 08 Oct 2013 2013 FY
2012 $9,327,500 +$2,357,500 +34% 01 Jul 2011 30 Jun 2012 10-K/A 08 Oct 2013 2013 FY
2011 $6,970,000 -$1,088,592 -14% 30 Jun 2010 30 Jun 2011 10-K/A 08 Oct 2013 2013 FY
2010 $8,058,592 01 Jul 2009 30 Jun 2010 10-K/A 26 Oct 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.